|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 49/00 | (2006.01) |
| A61K 38/00 | (2013.01) | ||
| C07K 14/00 | (2006.01) | ||
| C07K 14/78 | (2013.01) | ||
| C40B 50/00 | (2006.01) | ||
| C12N 15/1044 | (2013.01) | ||
| A61P 1/00 | (2018.01) | ||
| C40B 40/08 | (2006.01) | ||
| A61P 11/00 | (2018.01) | ||
| C40B 40/02 | (2006.01) | ||
| A61P 11/02 | (2018.01) | ||
| C40B 30/04 | (2006.01) | ||
| A61P 25/00 | (2018.01) | ||
| C07H 21/00 | (2006.01) | ||
| C12N 15/63 | (2006.01) | ||
| A61P 27/00 | (2018.01) | ||
| C12N 1/21 | (2006.01) | ||
| A61P 27/02 | (2018.01) | ||
| C12N 1/19 | (2006.01) | ||
| A61P 27/16 | (2018.01) | ||
| C12N 5/10 | (2006.01) | ||
| A61P 29/00 | (2018.01) | ||
| A61K 38/16 | (2006.01) | ||
| A61P 3/00 | (2018.01) | ||
| A61P 25/00 | (2006.01) | ||
| A61P 31/00 | (2018.01) | ||
| A61K 38/22 | (2006.01) | ||
| A61P 31/04 | (2018.01) | ||
| A61P 7/00 | (2006.01) | ||
| A61P 31/12 | (2018.01) | ||
| A61P 27/02 | (2006.01) | ||
| A61P 33/00 | (2018.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 35/00 | (2018.01) | ||
| A61P 9/00 | (2006.01) | ||
| A61P 37/00 | (2018.01) | ||
| A61P 37/02 | (2018.01) | ||
| A61P 43/00 | (2018.01) | ||
| A61P 7/00 | (2018.01) | ||
| A61P 9/00 | (2018.01) | ||
| A61P 9/10 | (2018.01) | ||
| Y02A 50/30 | (2018.01) |
| (11) | Number of the document | 3569256 |
| (13) | Kind of document | T |
| (96) | European patent application number | 19169579.0 |
| Date of filing the European patent application | 2011-04-29 | |
| (97) | Date of publication of the European application | 2019-11-20 |
| (45) | Date of publication and mention of the grant of the patent | 2022-06-15 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 32998010 P | 2010-04-30 | US |
| (72) |
JACOBS, Steven , US
|
| (73) |
Janssen Biotech, Inc. ,
800/850 Ridgeview Drive, Horsham, PA 19044,
US
|
| (54) | STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |
| STABILIZED FIBRONECTIN DOMAIN COMPOSITIONS, METHODS AND USES |